MM&M announced it would release its flagship report on marketing in the pharmaceutical industry in March.
“The proprietary survey of director-level-and-up biopharma and device marketing execs will showcase a wealth of exclusive research and offer insight into marketers’ current thinking via new data on budgets (and their growth/decline), channel usage and challenges/opportunities (such as the intensified influence of payers),” MM&M said in an email.
To read more, click here.
